NPI: 1457369381 · BAY SHORE, NY 11706 · General Acute Care Hospital · NPI assigned 08/04/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 08/04/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,977 | $788K |
| 2019 | 56,021 | $2.96M |
| 2020 | 114,639 | $6.74M |
| 2021 | 178,345 | $10.35M |
| 2022 | 165,926 | $9.17M |
| 2023 | 187,238 | $9.84M |
| 2024 | 156,776 | $7.60M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 38,395 | 36,347 | $6.63M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 44,009 | 12,144 | $5.30M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 32,025 | 30,149 | $5.20M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16,578 | 15,192 | $2.78M |
| 36415 | Collection of venous blood by venipuncture | 123,914 | 50,566 | $1.92M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,786 | 6,501 | $1.85M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,547 | 9,220 | $1.64M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,680 | 5,498 | $1.61M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,830 | 1,819 | $1.26M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,518 | 4,360 | $1.24M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,811 | 1,772 | $1.23M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8,541 | 8,059 | $1.14M |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 16,637 | 5,277 | $1.10M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,579 | 7,336 | $1.03M |
| G0378 | Hospital observation service, per hour | 4,246 | 3,847 | $1.02M |
| 80053 | Comprehensive metabolic panel | 39,831 | 36,665 | $1.00M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 691 | 689 | $571K |
| 59025 | Fetal non-stress test | 2,461 | 2,127 | $526K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8,615 | 7,956 | $525K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,609 | 1,579 | $458K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,891 | 1,487 | $447K |
| 95800 | 1,019 | 1,007 | $438K | |
| 95806 | 424 | 410 | $386K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8,941 | 7,450 | $376K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 429 | 427 | $358K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,231 | 1,211 | $333K |
| 12001 | 680 | 675 | $332K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,755 | 1,581 | $308K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 18,252 | 17,177 | $290K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 986 | 973 | $237K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 251 | 250 | $227K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 11,973 | 10,685 | $219K |
| 86850 | 6,487 | 6,210 | $218K | |
| 97161 | 2,075 | 2,072 | $208K | |
| 86901 | 6,478 | 6,203 | $204K | |
| 86900 | 6,481 | 6,207 | $202K | |
| C1889 | Implantable/insertable device, not otherwise classified | 469 | 466 | $201K |
| 0225U | 9,088 | 8,323 | $182K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,391 | 10,574 | $162K |
| 93970 | 236 | 234 | $157K | |
| 12011 | 308 | 307 | $155K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,838 | 6,652 | $154K |
| 88342 | 1,955 | 1,943 | $143K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,130 | 1,026 | $141K |
| 76801 | 1,357 | 1,237 | $139K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,128 | 1,043 | $126K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,031 | 2,000 | $126K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,247 | 4,164 | $124K |
| 97162 | 1,005 | 1,000 | $114K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,602 | 3,559 | $108K |
| 83880 | 3,343 | 3,224 | $103K | |
| 64483 | 120 | 117 | $96K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,301 | 5,879 | $82K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,178 | 2,167 | $77K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8,068 | 7,185 | $74K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 356 | 352 | $67K |
| 70498 | 240 | 239 | $65K | |
| 62323 | 102 | 102 | $64K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 197 | 196 | $64K |
| J3490 | Unclassified drugs | 8,680 | 7,999 | $63K |
| 76000 | 1,690 | 1,593 | $60K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 25,215 | 23,193 | $59K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 327 | 308 | $55K |
| J7030 | Infusion, normal saline solution , 1000 cc | 14,890 | 13,975 | $52K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 630 | 392 | $51K |
| 82803 | 2,315 | 2,210 | $48K | |
| C1769 | Guide wire | 385 | 379 | $43K |
| 90715 | 1,503 | 1,491 | $42K | |
| 87631 | 611 | 605 | $41K | |
| 12002 | 81 | 80 | $41K | |
| 93971 | 619 | 614 | $40K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,338 | 1,325 | $38K |
| 97165 | 300 | 300 | $37K | |
| 77002 | 86 | 65 | $36K | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 1,652 | 1,511 | $36K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,309 | 1,296 | $36K |
| 85610 | 9,152 | 8,796 | $35K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,840 | 1,828 | $35K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 43 | 43 | $35K |
| 97116 | 838 | 335 | $35K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 146 | 144 | $35K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 37 | 37 | $33K |
| 62321 | 48 | 47 | $33K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,919 | 1,842 | $33K |
| 20610 | 86 | 65 | $32K | |
| 86703 | 2,266 | 2,251 | $32K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 3,706 | 3,574 | $31K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 953 | 929 | $30K |
| 29125 | 122 | 121 | $30K | |
| 96376 | 2,375 | 2,109 | $27K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,468 | 3,761 | $27K |
| 10060 | 71 | 70 | $26K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 83 | 83 | $25K |
| 76830 | Ultrasound, transvaginal | 1,340 | 1,310 | $25K |
| 97535 | Self-care/home management training, each 15 minutes | 331 | 182 | $23K |
| 71046 | Radiologic examination, chest; 2 views | 6,966 | 6,848 | $21K |
| 84702 | 15,580 | 14,568 | $21K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 82 | 79 | $18K |
| 85027 | 12,612 | 11,562 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 31,482 | 29,026 | $14K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 243 | 240 | $14K |
| 71045 | Radiologic examination, chest; single view | 9,862 | 9,470 | $14K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,176 | 3,743 | $14K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 172 | 170 | $13K |
| 81025 | 4,012 | 3,929 | $13K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 112 | 110 | $13K |
| 70486 | 343 | 340 | $13K | |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 13 | 13 | $12K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 46 | 45 | $12K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,371 | 3,224 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 245 | 245 | $11K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 758 | 707 | $11K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 37 | 37 | $11K |
| 72131 | 68 | 66 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,426 | 9,861 | $11K |
| J7050 | Infusion, normal saline solution, 250 cc | 1,986 | 1,563 | $10K |
| 64493 | 12 | 12 | $10K | |
| J2704 | Injection, propofol, 10 mg | 3,778 | 3,659 | $10K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 925 | 874 | $10K |
| 85730 | 9,441 | 9,086 | $10K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 33 | 33 | $9K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 28 | 28 | $9K |
| 77003 | 658 | 616 | $8K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 32 | 32 | $8K |
| 29515 | 28 | 28 | $7K | |
| 71250 | 62 | 62 | $7K | |
| 74174 | 24 | 24 | $7K | |
| 81001 | 16,747 | 15,999 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,254 | 8,628 | $7K |
| 87486 | 259 | 257 | $6K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 831 | 798 | $6K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,930 | 2,690 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,384 | 1,233 | $6K |
| C9399 | Unclassified drugs or biologicals | 150 | 150 | $6K |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 53 | 49 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,310 | 10,945 | $6K |
| 97010 | 530 | 148 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,658 | 3,507 | $5K |
| 87581 | 257 | 257 | $5K | |
| 86769 | 381 | 364 | $5K | |
| 87641 | 132 | 131 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | 1,887 | 1,612 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | 930 | 900 | $4K |
| 70496 | 234 | 234 | $4K | |
| 93017 | 76 | 75 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,663 | 3,492 | $4K |
| 83735 | 5,475 | 5,267 | $4K | |
| 84484 | 10,273 | 9,266 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,064 | 2,976 | $4K |
| 59050 | 14 | 13 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,339 | 3,204 | $4K |
| 75574 | 14 | 14 | $4K | |
| 82962 | 7,689 | 6,791 | $3K | |
| 83690 | 11,668 | 10,970 | $3K | |
| 73610 | 1,364 | 1,329 | $3K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 85 | 63 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,179 | 3,114 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,683 | 1,630 | $2K |
| J3360 | Injection, diazepam, up to 5 mg | 115 | 108 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 472 | 453 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,088 | 2,072 | $2K |
| 85379 | 2,643 | 2,604 | $2K | |
| 36000 | 65 | 64 | $2K | |
| 88304 | 84 | 84 | $2K | |
| 83605 | 4,534 | 4,289 | $2K | |
| 73630 | 1,311 | 1,275 | $2K | |
| 97163 | 14 | 14 | $2K | |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 20 | 12 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,667 | 1,521 | $1K |
| 73130 | 1,348 | 1,310 | $1K | |
| 87040 | 1,788 | 1,731 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,184 | 1,166 | $1K |
| 84100 | 917 | 867 | $1K | |
| 81003 | 3,647 | 3,567 | $1K | |
| 73110 | 730 | 708 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 28 | 28 | $996.30 |
| 73030 | 1,047 | 1,010 | $987.05 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 375 | 350 | $828.67 |
| J1630 | Injection, haloperidol, up to 5 mg | 942 | 786 | $816.99 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 37 | 37 | $813.95 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 98 | 87 | $745.61 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 160 | 150 | $736.04 |
| 73564 | 576 | 560 | $733.32 | |
| 82728 | 227 | 223 | $730.34 | |
| 80061 | Lipid panel | 65 | 65 | $726.78 |
| 87186 | 1,649 | 1,613 | $546.98 | |
| 73562 | 498 | 483 | $544.81 | |
| S0028 | Injection, famotidine, 20 mg | 478 | 463 | $525.84 |
| 73590 | 361 | 353 | $524.56 | |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 65 | 36 | $487.60 |
| 64484 | 12 | 12 | $448.08 | |
| 82330 | 1,681 | 1,613 | $422.28 | |
| 84436 | 1,079 | 1,070 | $406.12 | |
| 87077 | 916 | 893 | $403.99 | |
| 82550 | 1,789 | 1,720 | $344.44 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 46 | 40 | $332.46 |
| 84132 | 1,582 | 1,515 | $322.29 | |
| 84295 | 1,522 | 1,459 | $293.40 | |
| 82435 | 1,519 | 1,457 | $274.79 | |
| 87640 | 136 | 134 | $274.67 | |
| 87800 | 13 | 13 | $253.15 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 17 | 12 | $248.91 |
| 82947 | 1,525 | 1,463 | $246.80 | |
| 86140 | 634 | 625 | $240.73 | |
| 73090 | 246 | 242 | $224.90 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 75 | 72 | $217.89 |
| 87070 | 70 | 68 | $150.18 | |
| 84480 | 280 | 278 | $139.29 | |
| 85014 | 1,540 | 1,478 | $139.02 | |
| 84466 | 14 | 13 | $137.31 | |
| 85018 | 1,493 | 1,434 | $135.36 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 218 | 194 | $119.23 |
| J1171 | Injection, hydromorphone, 0.1 mg | 31 | 28 | $114.19 |
| 85652 | 303 | 295 | $113.82 | |
| 84145 | 89 | 88 | $111.73 | |
| 86803 | 186 | 186 | $94.80 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 17 | 13 | $88.04 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 188 | 187 | $85.85 |
| 82553 | 448 | 423 | $65.28 | |
| 83540 | 14 | 13 | $55.25 | |
| 85384 | 29 | 25 | $54.09 | |
| 83615 | 44 | 39 | $43.62 | |
| 86780 | 47 | 46 | $37.30 | |
| 87081 | 198 | 197 | $32.73 | |
| 76870 | 16 | 15 | $30.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 12 | 12 | $26.50 |
| 73080 | 128 | 125 | $25.00 | |
| 82009 | 110 | 109 | $17.52 | |
| 73502 | 13 | 12 | $12.47 | |
| 74018 | 39 | 38 | $10.00 | |
| 99080 | 3,388 | 671 | $0.00 | |
| 73140 | 13 | 13 | $0.00 | |
| 99152 | 15 | 14 | $0.00 | |
| 84550 | 15 | 14 | $0.00 | |
| 83986 | 12 | 12 | $0.00 |